Analyst Michael Yee works at JEFFERIES and is focused on Healthcare, Industrials sectors with 696 price targets and ratings documented since 2008 spanning on 26 stocks. Analyst's average stock valuation to be materialised ratio is 54.62% with an average time for price targets to be met of 186.38 days.
Most recent stock forecast was given on ESPR, Esperion Therapeutics, Inc at 24-Feb-2023.
Michael Yee best performing recommendations are on ALGS.
The best stock recommendation documented was for MRNA (MODERNA, INC) at 7/13/2020. The price target of $90 was fulfilled within 4 days with a profit of $18.22 (25.38%) receiving and performance score of 63.46.
Average potential price target upside
Currently, out of the existing stock ratings of Michael Yee - 33547 which are a Buy (78.57%), 8907 which are a Hold (20.86%), 244 which are a Sell (0.57%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
35
$34.42 (5934.48%)
180
2 years 2 months 16 days ago
1/4 (25%)
$98.09 (180.48%)
205
Hold
6
$5.42 (934.48%)
42
2 years 10 months 23 days ago
6/8 (75%)
$11.62 (54.29%)
37
Hold
6
$5.42 (934.48%)
150
2 years 10 months 23 days ago
9/9 (100%)
$18.43 (16.56%)
274
Sell
6
$5.42 (934.48%)
60
3 years 5 months 8 days ago
7/7 (100%)
$-23.57 (-27.41%)
161
Hold
192
$191.42 (33003.45%)
222
4 years 6 months 18 days ago
1/3 (33.33%)
$51.7 (39.70%)
28
